Literature DB >> 23180186

Steroid-responsive hearing impairment in NMO-IgG/aquaporin-4-antibody-positive neuromyelitis optica.

S Jarius, F Lauda, B Wildemann, H Tumani.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23180186     DOI: 10.1007/s00415-012-6755-4

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  15 in total

1.  Impaired hearing in mice lacking aquaporin-4 water channels.

Authors:  J Li; A S Verkman
Journal:  J Biol Chem       Date:  2001-06-13       Impact factor: 5.157

2.  Testing for antibodies to human aquaporin-4 by ELISA: sensitivity, specificity, and direct comparison with immunohistochemistry.

Authors:  S Jarius; D Franciotta; F Paul; R Bergamaschi; P S Rommer; K Ruprecht; M Ringelstein; O Aktas; W Kristoferitsch; B Wildemann
Journal:  J Neurol Sci       Date:  2012-06-16       Impact factor: 3.181

Review 3.  AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance.

Authors:  Sven Jarius; Brigitte Wildemann
Journal:  Nat Rev Neurol       Date:  2010-07       Impact factor: 42.937

4.  Age-related hearing loss: aquaporin 4 gene expression changes in the mouse cochlea and auditory midbrain.

Authors:  Nathan Christensen; Mary D'Souza; Xiaoxia Zhu; Robert D Frisina
Journal:  Brain Res       Date:  2008-12-03       Impact factor: 3.252

5.  Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.

Authors:  Shanu F Roemer; Joseph E Parisi; Vanda A Lennon; Eduardo E Benarroch; Hans Lassmann; Wolfgang Bruck; Raul N Mandler; Brian G Weinshenker; Sean J Pittock; Dean M Wingerchuk; Claudia F Lucchinetti
Journal:  Brain       Date:  2007-02-04       Impact factor: 13.501

6.  Select types of supporting cell in the inner ear express aquaporin-4 water channel protein.

Authors:  Y Takumi; E A Nagelhus; J Eidet; A Matsubara; S Usami; H Shinkawa; S Nielsen; O P Ottersen
Journal:  Eur J Neurosci       Date:  1998-12       Impact factor: 3.386

Review 7.  Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica.

Authors:  Sven Jarius; Friedemann Paul; Diego Franciotta; Patrick Waters; Frauke Zipp; Reinhard Hohlfeld; Angela Vincent; Brigitte Wildemann
Journal:  Nat Clin Pract Neurol       Date:  2008-03-11

8.  Aquaporin 4 expression in the mammalian inner ear and its role in hearing.

Authors:  Anand N Mhatre; Ryan E Stern; Jiang Li; Anil K Lalwani
Journal:  Biochem Biophys Res Commun       Date:  2002-10-04       Impact factor: 3.575

9.  Spectrum of pediatric neuromyelitis optica.

Authors:  Timothy E Lotze; Jennifer L Northrop; George J Hutton; Benjamin Ross; Jade S Schiffman; Jill V Hunter
Journal:  Pediatrics       Date:  2008-10-06       Impact factor: 7.124

10.  Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients.

Authors:  Sven Jarius; Klemens Ruprecht; Brigitte Wildemann; Tania Kuempfel; Marius Ringelstein; Christian Geis; Ingo Kleiter; Christoph Kleinschnitz; Achim Berthele; Johannes Brettschneider; Kerstin Hellwig; Bernhard Hemmer; Ralf A Linker; Florian Lauda; Christoph A Mayer; Hayrettin Tumani; Arthur Melms; Corinna Trebst; Martin Stangel; Martin Marziniak; Frank Hoffmann; Sven Schippling; Jürgen H Faiss; Oliver Neuhaus; Barbara Ettrich; Christian Zentner; Kersten Guthke; Ulrich Hofstadt-van Oy; Reinhard Reuss; Hannah Pellkofer; Ulf Ziemann; Peter Kern; Klaus P Wandinger; Florian Then Bergh; Tobias Boettcher; Stefan Langel; Martin Liebetrau; Paulus S Rommer; Sabine Niehaus; Christoph Münch; Alexander Winkelmann; Uwe K Zettl U; Imke Metz; Christian Veauthier; Jörn P Sieb; Christian Wilke; Hans P Hartung; Orhan Aktas; Friedemann Paul
Journal:  J Neuroinflammation       Date:  2012-01-19       Impact factor: 8.322

View more
  10 in total

Review 1.  Common and Rare Manifestations of Neuromyelitis Optica Spectrum Disorder.

Authors:  Dominique Rosales; Ilya Kister
Journal:  Curr Allergy Asthma Rep       Date:  2016-06       Impact factor: 4.806

Review 2.  Neuromyelitis optica spectrum disorders.

Authors:  Eoin P Flanagan; Brian G Weinshenker
Journal:  Curr Neurol Neurosci Rep       Date:  2014-09       Impact factor: 5.081

3.  The history of neuromyelitis optica.

Authors:  Sven Jarius; Brigitte Wildemann
Journal:  J Neuroinflammation       Date:  2013-01-15       Impact factor: 8.322

Review 4.  Neuromyelitis optica: clinical features, immunopathogenesis and treatment.

Authors:  S Jarius; B Wildemann; F Paul
Journal:  Clin Exp Immunol       Date:  2014-05       Impact factor: 4.330

Review 5.  Neuromyelitis optica spectrum disorders: An update.

Authors:  Lekha Pandit
Journal:  Ann Indian Acad Neurol       Date:  2015-09       Impact factor: 1.383

6.  Neuromyelitis optica spectrum disorder with deafness and an extensive brainstem lesion.

Authors:  Asako Onda; Mikihiro Yamazaki; Takashi Shimoyama; Hiroshi Yaguchi
Journal:  Heliyon       Date:  2021-01-29

Review 7.  Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS).

Authors:  Corinna Trebst; Sven Jarius; Achim Berthele; Friedemann Paul; Sven Schippling; Brigitte Wildemann; Nadja Borisow; Ingo Kleiter; Orhan Aktas; Tania Kümpfel
Journal:  J Neurol       Date:  2013-11-23       Impact factor: 4.849

8.  Neuromyelitis optica in Austria in 2011: to bridge the gap between neuroepidemiological research and practice in a study population of 8.4 million people.

Authors:  Fahmy Aboul-Enein; Thomas Seifert-Held; Simone Mader; Bettina Kuenz; Andreas Lutterotti; Helmut Rauschka; Paulus Rommer; Fritz Leutmezer; Karl Vass; Agathe Flamm-Horak; Robert Stepansky; Wilfried Lang; Elisabeth Fertl; Thomas Schlager; Thomas Heller; Christian Eggers; Georg Safoschnik; Siegrid Fuchs; Jörg Kraus; Hamid Assar; Stefan Guggenberger; Martin Reisz; Peter Schnabl; Martina Komposch; Philipp Simschitz; Alena Skrobal; Alexander Moser; Mario Jeschow; Dorothea Stadlbauer; Manfred Freimüller; Michael Guger; Susanne Schmidegg; Claudia Franta; Vera Weiser; Stefan Koppi; Margret Niederkorn-Duft; Bettina Raber; Iris Schmeissner; Julia Jecel; Alexander Tinchon; Maria K Storch; Markus Reindl; Thomas Berger; Wolfgang Kristoferitsch
Journal:  PLoS One       Date:  2013-11-05       Impact factor: 3.240

9.  Systemic Lupus Erythematosus (SLE) Complicated by Neuromyelitis Optica (NMO - Devic's Disease): Clinic-Pathological Report and Review of the Literature.

Authors:  Mohammad Adawi; Bishara Bisharat; Abdalla Bowirrat
Journal:  Clin Med Insights Case Rep       Date:  2014-06-02

Review 10.  Complexity and wide range of neuromyelitis optica spectrum disorders: more than typical manifestations.

Authors:  Jinming Han; Meng-Ge Yang; Jie Zhu; Tao Jin
Journal:  Neuropsychiatr Dis Treat       Date:  2017-10-20       Impact factor: 2.570

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.